Taktak AF - Search Results

1

Conjunctival melanoma copy number alterations and correlation with mutation status, tumor features, and clinical outcome.

Kenawy N, Kalirai H, Sacco JJ, Lake SL, Heegaard S, Larsen AC, Finger PT, Milman T, Chin K, Mosci C, Lanza F, Moulin A, Schmitt CA, Caujolle JP, Maschi C, Marinkovic M, Taktak AF, Heimann H, Damato BE, Coupland SE. Kenawy N, et al. Among authors: taktak af. Pigment Cell Melanoma Res. 2019 Jul;32(4):564-575. doi: 10.1111/pcmr.12767. Epub 2019 Feb 19. Pigment Cell Melanoma Res. 2019. PMID: 30672666 Free PMC article.

2

Modelling survival after treatment of intraocular melanoma using artificial neural networks and Bayes theorem.

Taktak AF, Fisher AC, Damato BE. Taktak AF, et al. Phys Med Biol. 2004 Jan 7;49(1):87-98. doi: 10.1088/0031-9155/49/1/006. Phys Med Biol. 2004. PMID: 14971774

3

On the use of multi-objective evolutionary algorithms for survival analysis.

Setzkorn C, Taktak AF, Damato BE. Setzkorn C, et al. Among authors: taktak af. Biosystems. 2007 Jan;87(1):31-48. doi: 10.1016/j.biosystems.2006.03.002. Epub 2006 Mar 13. Biosystems. 2007. PMID: 16762491

4

The role and efficacy of non-linear models in decision making and prognostication.

Taktak AF, Fisher AC, Jones AS, Damato BE. Taktak AF, et al. Conf Proc IEEE Eng Med Biol Soc. 2004;2006:411-4. doi: 10.1109/IEMBS.2004.1403181. Conf Proc IEEE Eng Med Biol Soc. 2004. PMID: 17271699

5

Double-blind comparison of survival analysis models using a bespoke web system.

Taktak AF, Setzkorn C, Damato BE. Taktak AF, et al. Conf Proc IEEE Eng Med Biol Soc. 2006;2006:2466-7, 2469. doi: 10.1109/IEMBS.2006.259797. Conf Proc IEEE Eng Med Biol Soc. 2006. PMID: 17945716

6

Continuous and discrete time survival analysis: neural network approaches.

Eleuteri A, Aung MS, Taktak AF, Damato B, Lisboa PJ. Eleuteri A, et al. Among authors: taktak af. Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:5420-3. doi: 10.1109/IEMBS.2007.4353568. Annu Int Conf IEEE Eng Med Biol Soc. 2007. PMID: 18003234

7

Artificial neural networks estimating survival probability after treatment of choroidal melanoma.

Damato B, Eleuteri A, Fisher AC, Coupland SE, Taktak AF. Damato B, et al. Among authors: taktak af. Ophthalmology. 2008 Sep;115(9):1598-607. doi: 10.1016/j.ophtha.2008.01.032. Epub 2008 Mar 14. Ophthalmology. 2008. PMID: 18342942

8

Immunohistochemical assessment of mitotic count in uveal melanoma.

Angi M, Damato B, Kalirai H, Dodson A, Taktak A, Coupland SE. Angi M, et al. Acta Ophthalmol. 2011 Mar;89(2):e155-60. doi: 10.1111/j.1755-3768.2009.01769.x. Acta Ophthalmol. 2011. PMID: 19900200 Free article.

9

Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.

Lake SL, Coupland SE, Taktak AF, Damato BE. Lake SL, et al. Among authors: taktak af. Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4884-91. doi: 10.1167/iovs.09-5083. Epub 2010 May 5. Invest Ophthalmol Vis Sci. 2010. PMID: 20445121

10

Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.

Dopierala J, Damato BE, Lake SL, Taktak AF, Coupland SE. Dopierala J, et al. Among authors: taktak af. Invest Ophthalmol Vis Sci. 2010 Oct;51(10):4898-905. doi: 10.1167/iovs.09-5004. Epub 2010 May 19. Invest Ophthalmol Vis Sci. 2010. PMID: 20484589

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page